CYTOGENETIC RESPONSE IN CHRONIC MYELOCYTIC-LEUKEMIA (CML) USING RECOMBINANT ALPHA-2 INTERFERON (IFN) PLUS HYDROXYUREA (HU)

被引：0
|
作者：
GUILHOT, F [1 ]
BRIZARD, A [1 ]
HURET, JL [1 ]
DREYFUS, B [1 ]
DESMAREST, MC [1 ]
TANZER, J [1 ]
机构：
[1] HOP JEAN BERNARD,F-86021 POITIERS,FRANCE
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1988年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：215 / 215
页数：1
相关论文
共 50 条
  • [1] TREATMENT OF CHRONIC MYELOCYTIC-LEUKEMIA WITH RECOMBINANT ALPHA INTERFERON AND HYDROXYUREA
    GUILHOT, F
    TANZER, J
    BRIZARD, A
    DREYFUS, B
    HURET, JL
    DESMAREST, MC
    BRIAUT, S
    PRESSE MEDICALE, 1988, 17 (29): : 1494 - 1494
  • [2] A PHASE-I/II STUDY OF RECOMBINANT INTERFERON ALPHA-2A AND HYDROXYUREA FOR CHRONIC MYELOCYTIC-LEUKEMIA
    ANGER, B
    PORZSOLT, F
    LEICHTLE, R
    HEINZE, B
    BARTRAM, C
    HEIMPEL, H
    BLUT, 1989, 58 (06): : 275 - 278
  • [3] A MULTICENTRIC RANDOMIZED STUDY OF ALPHA-2B INTERFERON (IFN) AND HYDROXYUREA (HU) WITH OR WITHOUT CYTOSINE-ARABINOSIDE (ARA-C) IN PREVIOUSLY UNTREATED PATIENTS WITH PH+ CHRONIC MYELOCYTIC-LEUKEMIA (CML) - PRELIMINARY CYTOGENETIC RESULTS
    GUILHOT, F
    ABGRALL, JF
    HAROUSSEAU, JL
    BAUTERS, F
    BRICE, P
    DINE, G
    TILLY, H
    IFRAH, N
    CASSASUS, P
    ROCHANT, H
    CHRISTIAN, B
    GUERCI, A
    LAMAGNERE, JP
    LEPRISE, PY
    DUCLOS, B
    TANZER, J
    LEUKEMIA & LYMPHOMA, 1993, 11 : 181 - 183
  • [4] A randomized study comparing interferon (IFNα) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML)
    Kühr, T
    Burgstaller, S
    Apfelbeck, U
    Linkesch, W
    Seewann, H
    Fridrik, M
    Michlmayr, G
    Krieger, O
    Lutz, D
    Lin, W
    Pont, J
    Köck, L
    Abbrederis, K
    Baldinger, C
    Buder, R
    Geissler, D
    Hausmaninger, H
    Lang, A
    Zabernigg, A
    Duba, C
    Hilbe, W
    Eisterer, W
    Fiegl, M
    Greil, R
    Gastl, G
    Thaler, J
    LEUKEMIA RESEARCH, 2003, 27 (05) : 405 - 411
  • [5] INVESTIGATION OF RECOMBINANT HUMAN INTERFERON ALPHA-2 (RIFN-ALPHA-2) IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
    NIEDERLE, N
    MAHMOUD, HK
    KLOKE, O
    BECHER, R
    BLUT, 1985, 51 (03): : 232 - 232
  • [6] INTERFERON-ALPHA-2 (IFN) PLUS HYDROXYUREA FOR TREATMENT OF JUVENILE CHRONIC MYELOGENOUS LEUKEMIA
    SUTTORP, M
    RISTER, M
    SCHMITZ, N
    MEDICAL AND PEDIATRIC ONCOLOGY, 1994, 22 (05): : 358 - 359
  • [7] Treatment of patients with multiply myeloma (MM) and chronic myelogenous leukemia (CML) with alpha-2 interferon (IFN).
    Bessmeltsev, SS
    Rukavitsyn, OA
    Abdulkadyrov, KM
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 711 - 711
  • [8] RESPONSE AND TOXICITY TO ALPHA-INTERFERON IN CHILDHOOD PHILADELPHIA-CHROMOSOME POSITIVE (PH+) CHRONIC MYELOCYTIC-LEUKEMIA (CML)
    DOW, LW
    CULBERT, SJ
    KENNEDY, W
    PINKEL, DP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 224 - 224
  • [9] CHRONIC MYELOCYTIC-LEUKEMIA - REDUCTION OF INVITRO PROLIFERATION OF HEMATOPOIETIC PROGENITOR CELLS IN PATIENTS TREATED WITH RECOMBINANT ALPHA-INTERFERON (IFN ALPHA-2B)
    WANDL, UB
    NIEDERLE, N
    KLOKE, O
    OPALKA, B
    SCHMIDT, CG
    BLUT, 1986, 53 (03): : 237 - 237
  • [10] Clinical response and hematological toxicity to low dose alpha interferon (IFN) following hydroxyurea (HU) induced cytoreduction in a patient with variant Philadelphia chromosome positive (Ph Chr+) chronic myelocytic leukemia (CML).
    Hartung, B
    Besley, D
    Lopez, F
    Yee, S
    Mann, B
    BLOOD, 1997, 90 (10) : 3991 - 3991
12345